Charles Smith

Ask VT AI
View News Summary
  • Altria's Q3 earnings beat estimates, but shares fell on a weak outlook and persistent industry challenges.
  • Vulcan Materials reports strong Q3 results, expects continued growth in construction materials demand driven by infrastructure spending.
  • Novo Nordisk challenges Pfizer's acquisition of Metsera with a $6.5 billion bid, sparking a high-stakes contest for obesity and GLP-1 assets.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Ask VT AI
View News Summary
  • Altria's Q3 earnings beat estimates, but shares fell on a weak outlook and persistent industry challenges.
  • Vulcan Materials reports strong Q3 results, expects continued growth in construction materials demand driven by infrastructure spending.
  • Novo Nordisk challenges Pfizer's acquisition of Metsera with a $6.5 billion bid, sparking a high-stakes contest for obesity and GLP-1 assets.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Most Reported By
News from Charles Smith